+91 7986995600
seclislabs@gmail.com
Contact Us
Home › Cardiovascular Therapy › LEADTEL C
Cardiovascular Therapy

LEADTEL C

Telmisartan 40mg + Cilnidipine 10mg

Dosage Form Tablets
Packing 10x10 ALU
MRP ₹1499
Prescribed By Cardiologist, General Physician, Nephrologist, Endocrinologist, Internal Medicine

Quick Facts

Form Tablets
Pack 10x10 ALU
MRP Rs.1499
Prescribed By Cardiologist, General Physician, Nephrologist, Endocrinologist

Key Benefits

01
ARB + fourth-generation CCB for dual antihypertensive action.
02
Double kidney protection from both Telmisartan and Cilnidipine.
03
Particularly beneficial for diabetic hypertensive patients.
04
Convenient single tablet combination.

Mechanism of Action

Telmisartan blocks angiotensin II to reduce blood pressure and protect the kidneys. Cilnidipine blocks L- and N-type calcium channels to dilate blood vessels and additionally reduce urinary protein loss. Together they provide dual-mechanism BP control with enhanced kidney protection.

Indications

Hypertension, hypertension in diabetic or kidney disease patients.

Dosage & Administration

Take as prescribed by your doctor or healthcare professional. Do not self-medicate.

Why LEADTEL C?

LEADTEL C combines two antihypertensives that each independently protect the kidneys — making it the preferred dual combination for hypertensive patients with diabetes or chronic kidney disease.

Interested in franchising LEADTEL C?

Get exclusive monopoly rights in your territory. WHO-GMP certified. Pan India coverage with dedicated support.

📢

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.

Scroll to Top